165 related articles for article (PubMed ID: 32915353)
1. Serum microRNA is a biomarker for post-operative monitoring in glioma.
Morokoff A; Jones J; Nguyen H; Ma C; Lasocki A; Gaillard F; Bennett I; Luwor R; Stylli S; Paradiso L; Koldej R; Paldor I; Molania R; Speed TP; Webb A; Infusini G; Li J; Malpas C; Kalincik T; Drummond K; Siegal T; Kaye AH
J Neurooncol; 2020 Sep; 149(3):391-400. PubMed ID: 32915353
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
3. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
4. Identification of miRNA signatures in serum exosomes as a potential biomarker after radiotherapy treatment in glioma patients.
Li Z; Ye L; Wang L; Quan R; Zhou Y; Li X
Ann Diagn Pathol; 2020 Feb; 44():151436. PubMed ID: 31865249
[TBL] [Abstract][Full Text] [Related]
5. Circulating biomarkers for high-grade glioma.
Loo HK; Mathen P; Lee J; Camphausen K
Biomark Med; 2019 Feb; 13(3):161-165. PubMed ID: 30806515
[No Abstract] [Full Text] [Related]
6. Discovery of 5-Signature Predicting Survival of Patients with Lower-Grade Glioma.
Xiao H; Bai J; Yan M; Ji K; Tian W; Liu D; Ning T; Liu X; Zou J
World Neurosurg; 2019 Jun; 126():e765-e772. PubMed ID: 30853516
[TBL] [Abstract][Full Text] [Related]
7. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients.
Chen W; Yu Q; Chen B; Lu X; Li Q
Oncotarget; 2016 Aug; 7(33):53392-53413. PubMed ID: 27438144
[TBL] [Abstract][Full Text] [Related]
9. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
10. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
[TBL] [Abstract][Full Text] [Related]
11. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with high-grade glioma treated with bevacizumab.
Siegal T; Charbit H; Paldor I; Zelikovitch B; Canello T; Benis A; Wong ML; Morokoff AP; Kaye AH; Lavon I
J Neurosurg; 2016 Oct; 125(4):1008-1015. PubMed ID: 26799295
[TBL] [Abstract][Full Text] [Related]
13. Plasma miR-454-3p as a potential prognostic indicator in human glioma.
Shao N; Wang L; Xue L; Wang R; Lan Q
Neurol Sci; 2015 Feb; 36(2):309-13. PubMed ID: 25190548
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
15. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.
Lee JC; Zhao JT; Clifton-Bligh RJ; Gill A; Gundara JS; Ip JC; Glover A; Sywak MS; Delbridge LW; Robinson BG; Sidhu SB
Cancer; 2013 Dec; 119(24):4358-65. PubMed ID: 24301304
[TBL] [Abstract][Full Text] [Related]
17. A miRNA signature for defining aggressive phenotype and prognosis in gliomas.
Barbano R; Palumbo O; Pasculli B; Galasso M; Volinia S; D'Angelo V; Icolaro N; Coco M; Dimitri L; Graziano P; Copetti M; Valori VM; Maiello E; Carella M; Fazio VM; Parrella P
PLoS One; 2014; 9(10):e108950. PubMed ID: 25279461
[TBL] [Abstract][Full Text] [Related]
18. A novel serum microRNA-based identification and classification biomarker of human glioma.
Xing W; Zeng C
Tumour Biol; 2017 May; 39(5):1010428317705339. PubMed ID: 28475008
[TBL] [Abstract][Full Text] [Related]
19. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
[TBL] [Abstract][Full Text] [Related]
20. Identification of Dysregulated microRNAs in Glioma Using RNA-sequencing.
Liu C; Ge YY; Xie XX; Luo B; Shen N; Liao XS; Bi SQ; Xu T; Xiao SW; Zhang QM
Curr Med Sci; 2021 Apr; 41(2):356-367. PubMed ID: 33877554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
